Tag: MORT
Substantial Mortality Benefits Expected From Optimal Medication Use for HFrEF
1,188,277 deaths could potentially be prevented over 12 months with optimal implementation of quadruple guideline-directed medical therapy
Disparities Observed in Mortality During COVID-19 Pandemic
18.3 percent fewer deaths would have occurred had the rate of excess mortality seen in Whites been the same in total population
IDSA: 1999 to 2019 Saw Decrease in Sepsis-Related Mortality Rate in Children
Non-Hispanic Black to non-Hispanic White sepsis-related mortality ratio was 2.7, which did not change over time
Native Hawaiian and Pacific Islander Adults Have High CVD Mortality
Age-standardized mortality rate for CVD was third highest for NHPI, after Black and White adults, and was 1.5 times higher than for Asians
Daily Rainfall Intensity Linked to Varying Health Effects
Extreme events are associated with increased risk for all-cause, cardiovascular, and respiratory mortality
Mortality Increased With Delayed Admission for Patients With Hip Fracture
Increased mortality risk at 90 days and final follow-up seen in association with delayed disposition
Increasing Amount of Breast Cancer-Specific Death Due to Stage 1, 2 Disease
Authors say strategies are needed to identify early-stage breast cancer survivors at risk for recurrence
Urine Albumin-to-Creatinine Ratio Indicates Risk in Rheumatoid Arthritis
Risk for all-cause mortality increased in RA patients with microalbuminuria
Tobacco-Free Generation Could Prevent 40 Percent of Predicted Lung Cancer Deaths Globally
Most of the potential prevented deaths would occur in low- and middle-income countries
Subclinical Atherosclerosis Burden Linked to All-Cause Mortality
Carotid plaque burden and coronary artery calcium score both significantly linked to all-cause mortality in asymptomatic individuals
